Our News on Newswise

TCT 2020 Is Now a Virtual Event: TCT Connect

The Cardiovascular Research Foundation (CRF) has announced that Transcatheter Cardiovascular Therapeutics (TCT) 2020 will now take place as a virtual event called TCT Connect. The event will take place online October 14-18, 2020 and feature live...
28-May-2020 11:35 AM EDT Add to Favorites

PCR and CRF Announce Partners in Learning Virtual Sessions

PCR and CRF are pleased to announce the creation of virtual Partners in Learning sessions that will be broadcast during the PCR e-Course (June 25-27, 2020) and CRF’s TVT Connect meeting (June 18-28, 2020). The sessions, which will cover coronary...
28-May-2020 10:50 AM EDT Add to Favorites

Introducing TVT Connect

The Cardiovascular Research Foundation (CRF) has announced that TVT Connect, the Structural Heart Summit, will take place online June 18-28, 2020. TVT Connect features expertly developed series, late-breaking clinical science, challenging cases,...
22-May-2020 4:50 PM EDT Add to Favorites

Newswise: TAVI20_Social-Media-02-Twitter.png

PCR and TCT Announce the Creation of a New Educational Program: Partners in Learning

PCR and TCT are proud to announce the creation of a new educational program: “Partners in Learning.” The first of its kind will focus on TAVI practitioners, taking place on 21-22 March 2020 in Sao Paulo, Brazil. It is the first ever stand-alone...
21-Jan-2020 10:35 AM EST Add to Favorites

New Self-expanding TAVR Prosthesis Does Not Meet Non-Inferiority Compared to SAPIEN 3

The first randomized trial to compare the safety and efficacy of the new ACURATE neo transcatheter heart valve with the SAPIEN 3 TAVR device did not meet non-inferiority in patients with severe aortic stenosis.
30-Sep-2019 4:00 AM EDT Add to Favorites

New TAVR System Safe and Effective for High-Risk Surgical Patients with Severe Aortic Stenosis

The Portico IDE study found that 30-day safety and one-year effectiveness outcomes of a novel self-expanding transcatheter aortic valve replacement (TAVR) system for patients with severe aortic stenosis (AS) at high or extreme-risk for surgery was...
30-Sep-2019 4:00 AM EDT Add to Favorites

Three-Year COAPT Data Demonstrates Continued Safety and Effectiveness in Patients with Heart Failure and Secondary Mitral Regurgitation

The three-year results from the COAPT trial demonstrated that reducing severe secondary mitral regurgitation (SMR) with the MitraClip device safely improves prognosis in selected heart failure (HF) patients. In addition, those patients that crossed...
30-Sep-2019 4:00 AM EDT Add to Favorites

New Five-Year Data Shows Similar Outcomes for TAVR and SAVR in Patients with Severe Aortic Stenosis and Intermediate Surgical Risk

Five-year results from the PARTNER 2A trial found that patients with severe aortic stenosis (AS) and intermediate surgical risk who underwent transcatheter aortic valve replacement (TAVR) had similar rates of death and disabling stroke compared to...
30-Sep-2019 4:00 AM EDT Add to Favorites


See All News

Our Experts on Newswise

CRF to Hold Free Seminar on Living with Heart Failure for Patients and Caregivers

CRF will hold a free seminar, “Broken Hearts: Living with Heart Failure,” on Tuesday, June 6, 2017 for heart failure patients and caregivers at NewYork-Presbyterian Hospital. The seminar will focus on providing both patients and caregivers a...
9-May-2017 12:05 PM EDT

See All Experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.

About

The Cardiovascular Research Foundation (CRF) is a nonprofit research and educational organization dedicated to helping doctors improve survival and quality of life for people suffering from heart and vascular disease. For over 25 years, CRF has helped pioneer innovations in interventional cardiology and has educated doctors on the latest treatments for heart disease.

CRF works to identify, develop and promote the latest advancements in the treatment of heart and vascular disease. By covering all aspects of the research continuum, we’re able to accelerate the speed with which breakthrough therapies reach patients through doctors, improving survival rates and quality of life for patients worldwide.

CRF carries out its mission by pursuing three basic goals:

Innovate
The CRF Skirball Center for Innovation guides early ideas and innovations through comprehensive preclinical research programs to introduce practical clinical therapies to patients.

Investigate
The CRF Clinical Trials Center plans and executes clinical investigations from first-in-man studies to large, multicenter, international trials and provides expert, independent qualitative and quantitative analyses of clinical and imaging data.

Educate
The CRF Center for Education trains practitioners in advanced techniques and innovations at more than 50 educational meetings and conferences each year, including the annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

CRF is a 501(c)3 nonprofit organization.

Contacts

Irma Damhuis
Director, External Relations

idamhuis@crf.org

646-434-4690

Judy Romero
Associate Director, External Relations

jromero@crf.org

646-434-4608

David Harrison
Harrison Communications

david@harrisoncommunications.net

410-804-1728

Twitter

close
0.28804